309 related articles for article (PubMed ID: 34960055)
41. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors.
Massi D; Marconi C; Franchi A; Bianchini F; Paglierani M; Ketabchi S; Miracco C; Santucci M; Calorini L
Hum Pathol; 2007 Oct; 38(10):1516-25. PubMed ID: 17640716
[TBL] [Abstract][Full Text] [Related]
42. In vivo role of Arabidopsis arginase in arginine metabolism and abiotic stress response.
Shi HT; Chan ZL
Plant Signal Behav; 2013 May; 8(5):e24138. PubMed ID: 23470718
[TBL] [Abstract][Full Text] [Related]
43. Arginase: an emerging key player in the mammalian immune system.
Munder M
Br J Pharmacol; 2009 Oct; 158(3):638-51. PubMed ID: 19764983
[TBL] [Abstract][Full Text] [Related]
44. Expression of arginase II in prostate cancer.
Mumenthaler SM; Yu H; Tze S; Cederbaum SD; Pegg AE; Seligson DB; Grody WW
Int J Oncol; 2008 Feb; 32(2):357-65. PubMed ID: 18202758
[TBL] [Abstract][Full Text] [Related]
45. NG-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms.
Buga GM; Wei LH; Bauer PM; Fukuto JM; Ignarro LJ
Am J Physiol; 1998 Oct; 275(4):R1256-64. PubMed ID: 9756558
[TBL] [Abstract][Full Text] [Related]
46. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.
Bronte V; Kasic T; Gri G; Gallana K; Borsellino G; Marigo I; Battistini L; Iafrate M; Prayer-Galetti T; Pagano F; Viola A
J Exp Med; 2005 Apr; 201(8):1257-68. PubMed ID: 15824085
[TBL] [Abstract][Full Text] [Related]
47. Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity.
Cimen Bozkus C; Elzey BD; Crist SA; Ellies LG; Ratliff TL
J Immunol; 2015 Dec; 195(11):5237-50. PubMed ID: 26491198
[TBL] [Abstract][Full Text] [Related]
48. Regulation of arginine transport and metabolism by protein kinase Calpha in endothelial cells: stimulation of CAT2 transporters and arginase activity.
Visigalli R; Barilli A; Parolari A; Sala R; Rotoli BM; Bussolati O; Gazzola GC; Dall'Asta V
J Mol Cell Cardiol; 2010 Aug; 49(2):260-70. PubMed ID: 20430034
[TBL] [Abstract][Full Text] [Related]
49. Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancer.
Rigamonti N; Capuano G; Ricupito A; Jachetti E; Grioni M; Generoso L; Freschi M; Bellone M
Clin Cancer Res; 2011 Mar; 17(5):1012-23. PubMed ID: 21248302
[TBL] [Abstract][Full Text] [Related]
50. Utilizing precision medicine to modulate the prostate tumor microenvironment and enhance immunotherapy.
Olson B; Patnaik A
Urol Oncol; 2019 Aug; 37(8):535-542. PubMed ID: 30503851
[TBL] [Abstract][Full Text] [Related]
51. A role for PPARα in the regulation of arginine metabolism and nitric oxide synthesis.
Guelzim N; Mariotti F; Martin PG; Lasserre F; Pineau T; Hermier D
Amino Acids; 2011 Oct; 41(4):969-79. PubMed ID: 21063737
[TBL] [Abstract][Full Text] [Related]
52. [Physiological function of arginine and its metabolites in plants].
Yang HQ; Gao HJ
Zhi Wu Sheng Li Yu Fen Zi Sheng Wu Xue Xue Bao; 2007 Feb; 33(1):1-8. PubMed ID: 17287563
[TBL] [Abstract][Full Text] [Related]
53. Myeloid-derived suppressor cells reveal radioprotective properties through arginase-induced l-arginine depletion.
Leonard W; Dufait I; Schwarze JK; Law K; Engels B; Jiang H; Van den Berge D; Gevaert T; Storme G; Verovski V; Breckpot K; De Ridder M
Radiother Oncol; 2016 May; 119(2):291-9. PubMed ID: 26874542
[TBL] [Abstract][Full Text] [Related]
54. Enhanced utilization and altered metabolism of arginine in inflammatory macrophages caused by raised nitric oxide synthesis.
Müllner N; Lázár A; Hrabák A
Int J Biochem Cell Biol; 2002 Sep; 34(9):1080-90. PubMed ID: 12009303
[TBL] [Abstract][Full Text] [Related]
55. Metabolomic Reprogramming of C57BL/6-Macrophages during Early Infection with
Mamani-Huanca M; Muxel SM; Acuña SM; Floeter-Winter LM; Barbas C; López-Gonzálvez Á
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206906
[No Abstract] [Full Text] [Related]
56. Arginase modulates nitric oxide production in activated macrophages.
Chang CI; Liao JC; Kuo L
Am J Physiol; 1998 Jan; 274(1):H342-8. PubMed ID: 9458885
[TBL] [Abstract][Full Text] [Related]
57. Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator.
Das P; Lahiri A; Lahiri A; Chakravortty D
PLoS Pathog; 2010 Jun; 6(6):e1000899. PubMed ID: 20585552
[TBL] [Abstract][Full Text] [Related]
58. L-arginine metabolism in immune-mediated glomerulonephritis in the rat.
Ketteler M; Ikegaya N; Brees DK; Border WA; Noble NA
Am J Kidney Dis; 1996 Dec; 28(6):878-87. PubMed ID: 8957040
[TBL] [Abstract][Full Text] [Related]
59. Arginine and asthma.
Morris CR
Nestle Nutr Inst Workshop Ser; 2013; 77():1-15. PubMed ID: 24107492
[TBL] [Abstract][Full Text] [Related]
60. Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells.
Topal G; Brunet A; Walch L; Boucher JL; David-Dufilho M
J Pharmacol Exp Ther; 2006 Sep; 318(3):1368-74. PubMed ID: 16801455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]